Feldman C, Anderson R. Brief review: Cardiac complications and platelet activation in COVID-19 infection.
Afr J Thorac Crit Care Med 2020;
26:10.7196/AJTCCM.2020.v26i3.107. [PMID:
34235425 PMCID:
PMC7433708 DOI:
10.7196/ajtccm.2020.v26i3.107]
[Citation(s) in RCA: 1] [Impact Index Per Article: 0.2] [Reference Citation Analysis] [Abstract] [Key Words] [Track Full Text] [Download PDF] [Figures] [Journal Information] [Subscribe] [Scholar Register] [Accepted: 07/23/2020] [Indexed: 12/19/2022] Open
Abstract
COVID-19 pneumonia, much like that of bacterial and viral community-acquired pneumonia before it, is accompanied by a high rate of cardio- and cerebrovascular events that are associated with an increased risk of complications and a greater mortality. Although the mechanisms underlying the pathogenesis of these adverse events are not entirely clear and may be multifactorial, platelets appear to have a prominent aetiologic role and this, together with an overview of the clinical evidence, forms the basis of this short review.
Collapse